CNH Industrial
CNH
12.46
-0.81
-6.10%
CNH Industrial
US · CNH
#1090 by market cap
Listed 1970
12.46
-0.81
-6.10%
Live - 5344 symbols - heartbeat 260s ago
· 2026-10-08 07:06
Pre-market
12.33
-1.04%
After-hours
12.52
+0.48%
Overnight
12.46
0.00%
- Market cap
- 15.42B
- P/E (TTM)i
- 47.92
- P/Bi
- 1.99
- EPSi
- 0.41
- Div yieldi
- 0.80%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on CNH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.73, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -8.78% YoY
Margins
- Gross margin
- 31.53%
- Operating margin
- 15.50%
- Net margin
- 2.82%
Key ratios & quality
- Enterprise valuei
- 39.61B
- Altman Z-Scorei
- 1.73
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 29.71B | 28.08B | 14.78B | 19.50B | 23.55B | 24.69B | 19.84B | 18.10B |
| Gross profit | 6.75B | 6.25B | 3.63B | 5.39B | 6.75B | 7.85B | 6.49B | 5.71B |
| Selling & admin expenses | 2.35B | 2.22B | 1.30B | 1.45B | 1.75B | 1.86B | 1.71B | 1.88B |
| Research & development | 1.06B | 1.03B | 493.00M | 642.00M | 866.00M | 1.04B | 924.00M | 1.03B |
| Operating profit | 3.34B | 3.00B | 1.84B | 3.29B | 4.14B | 4.95B | 3.85B | 2.81B |
| Pretax profit | 1.47B | 1.17B | -179.00M | 1.94B | 2.68B | 2.70B | 1.46B | 620.00M |
| Tax | 417.00M | -271.00M | 85.00M | 229.00M | 747.00M | 594.00M | 336.00M | 184.00M |
| Net profit | 1.10B | 1.45B | -438.00M | 1.76B | 2.04B | 2.29B | 1.26B | 505.00M |
| Basic EPS | 1 | 1 | 0 | 1 | 2 | 2 | 1 | 0 |
| Diluted EPS | 0.78 | 1.05 | -0.36 | 1.27 | 1.49 | 1.69 | 0.99 | 0.41 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.83B | 4.71B | 4.40B | 5.16B | 3.83B | 4.80B |
| Gross profit | 1.26B | 1.52B | 1.40B | 1.52B | 1.22B | 1.41B |
| Selling & admin expenses | 386.00M | 478.00M | 549.00M | 463.00M | 465.00M | 494.00M |
| Research & development | 184.00M | 218.00M | 281.00M | 342.00M | 232.00M | 230.00M |
| Operating profit | 689.00M | 823.00M | 574.00M | 719.00M | 524.00M | 683.00M |
| Pretax profit | 162.00M | 275.00M | 51.00M | 132.00M | 13.00M | 172.00M |
| Tax | 47.00M | 76.00M | 1.00M | 60.00M | 4.00M | 43.00M |
| Net profit | 132.00M | 217.00M | 67.00M | 89.00M | 10.00M | 141.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.10 | 0.17 | 0.06 | 0.07 | 0.01 | 0.11 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 32.10B | 32.70B | 34.61B | 39.18B | 29.67B | 35.35B | 32.02B | 31.41B |
| Cash & ST investments | 5.03B | 4.88B | 8.79B | 5.04B | 4.38B | 4.32B | 3.19B | 2.58B |
| Inventory | 6.73B | 7.08B | 6.02B | 4.22B | 4.81B | 5.55B | 4.78B | 4.65B |
| Total assets | 46.10B | 47.35B | 48.72B | 49.42B | 39.38B | 46.27B | 42.93B | 42.75B |
| Total current liabilities | 9.23B | 8.77B | 9.75B | 17.72B | 5.63B | 17.46B | 3.96B | 14.11B |
| Short-term debt | -- | -- | -- | -- | -- | 11.48B | -- | 10.02B |
| Long-term debt | 24.45B | 24.85B | 26.05B | 20.90B | 22.96B | 15.85B | 26.88B | 16.74B |
| Total liabilities | 41,002,000,000.00 | 41,196,000,000.00 | 43,690,000,000.00 | 42,563,000,000.00 | 32,405,000,000.00 | 38,117,000,000.00 | 35,165,000,000.00 | 34,922,000,000.00 |
| Total equity | 5.10B | 6.16B | 5.03B | 6.85B | 6.98B | 8.15B | 7.77B | 7.83B |
| Retained earnings | 2.60B | 3.81B | 3.28B | 4.82B | 7.91B | 9.65B | 10.31B | 10.51B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 30.98B | 32.21B | 31.77B | 31.41B | 30.60B | 30.62B |
| Cash & ST investments | 1.70B | 2.51B | 2.30B | 2.58B | 1.60B | 1.87B |
| Inventory | 5.16B | 5.22B | 5.35B | 4.65B | 5.23B | 5.17B |
| Total assets | 42.06B | 43.69B | 43.26B | 42.75B | 42.04B | 42.17B |
| Total current liabilities | 3.89B | 4.12B | 4.03B | 14.11B | 4.26B | 4.34B |
| Short-term debt | -- | -- | -- | 10.02B | -- | -- |
| Long-term debt | 26.01B | 27.41B | 27.13B | 16.74B | 25.90B | 25.97B |
| Total liabilities | 34,098,000,000.00 | 35,853,000,000.00 | 35,421,000,000.00 | 34,922,000,000.00 | 34,170,000,000.00 | 34,319,000,000.00 |
| Total equity | 7.96B | 7.83B | 7.84B | 7.83B | 7.87B | 7.85B |
| Retained earnings | 10.44B | 10.34B | 10.42B | 10.51B | 10.51B | 10.53B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.55B | 1.83B | 5.53B | 4.08B | 557.00M | 907.00M | 1.97B | 2.54B |
| Depreciation & amortization | 1.34B | 1.22B | 538.00M | 537.00M | 535.00M | 564.00M | 605.00M | 629.00M |
| Free cash flow | 652.00M | -136.00M | 4.68B | 3.16B | -442.00M | -288.00M | 782.00M | 1.34B |
| Dividends paid | -243.00M | -283.00M | -8.00M | -188.00M | -423.00M | -538.00M | -607.00M | -333.00M |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -153.00M | -652.00M | -702.00M | -100.00M |
| Ending cash balance | 5.80B | 5.77B | 9.63B | 6.86B | 5.13B | 5.05B | 3.87B | 3.23B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 162.00M | 772.00M | 659.00M | 945.00M | 35.00M | 145.00M |
| Depreciation & amortization | 150.00M | 156.00M | 159.00M | 164.00M | 166.00M | 166.00M |
| Free cash flow | -102.00M | 520.00M | 389.00M | 533.00M | -183.00M | -128.00M |
| Dividends paid | -1.00M | -320.00M | -1.00M | -11.00M | -1.00M | -126.00M |
| Stock buybacks / issuance | -5.00M | 0 | -50.00M | -45.00M | -26.00M | -36.00M |
| Ending cash balance | 2.40B | 3.15B | 2.96B | 3.23B | 2.34B | 2.46B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.64 | 25.57 | -8.97 | 29.49 | 29.61 | 31.53 | 15.81 | 6.63 |
| ROA %i | 2.26 | 3.04 | -1.03 | 3.51 | 4.57 | 5.53 | 2.79 | 1.19 |
| ROIC %i | 5.52 | 6.59 | 0.38 | 7.11 | 10.03 | 8.85 | 7.04 | 4.46 |
| 5-year avg ROE %i | 8.65 | 10.88 | 8.04 | 15.08 | 19.75 | 21.22 | 19.29 | 22.41 |
| EBIT margin %i | 7.67 | 7.01 | 0.66 | 7.71 | 14.50 | 16.40 | 15.47 | 11.62 |
| FCF / sales %i | 2.19 | -- | 14.13 | 6.13 | -- | -- | 3.94 | 7.41 |
| Current ratioi | 3.48 | 3.73 | 3.55 | 2.21 | 5.27 | 2.02 | 8.08 | 2.23 |
| Quick ratioi | 2.66 | 2.82 | 2.85 | 1.16 | 4.28 | 1.67 | 6.71 | 1.85 |
| Debt / assetsi | 53.03 | 53.44 | 54.41 | 42.68 | 58.89 | 59.71 | 63.27 | 63.24 |
| LT debt / equityi | 484.73 | 416.10 | 540.17 | 311.20 | 334.78 | 201.11 | 355.04 | 220.10 |
| Interest coveragei | 2.81 | 2.47 | 0.26 | 4.32 | 4.65 | 3.01 | 1.90 | 1.42 |
| Revenue CAGR (3Y) %i | 4.66 | 3.82 | -18.89 | -13.10 | -5.69 | 18.65 | 0.58 | -8.41 |
| Net income CAGR (3Y) %i | 61.62 | -- | -- | 17.28 | 12.58 | -- | -10.24 | -36.89 |
| FCF CAGR (3Y) %i | 32.70 | -- | 95.16 | 69.25 | -- | -- | -37.22 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 12.83 | 10.79 | 7.77 | 6.63 | 4.95 | 4.02 |
| ROA %i | 2.30 | 1.88 | 1.37 | 1.19 | 0.92 | 0.72 |
| ROIC %i | 6.25 | 5.49 | 4.76 | 4.46 | 4.19 | 3.94 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.84 | 14.16 | 12.63 | 11.62 | 10.81 | 10.26 |
| FCF / sales %i | 9.42 | 11.82 | 11.36 | 7.41 | 6.96 | 3.36 |
| Current ratioi | 7.96 | 7.81 | 7.88 | 2.23 | 7.19 | 7.06 |
| Quick ratioi | 6.46 | 6.39 | 6.39 | 1.85 | 5.78 | 5.73 |
| Debt / assetsi | 62.52 | 63.39 | 63.38 | 63.24 | 62.31 | 62.26 |
| LT debt / equityi | 335.43 | 359.06 | 354.57 | 220.10 | 337.00 | 338.51 |
| Interest coveragei | 1.77 | 1.68 | 1.48 | 1.42 | 1.32 | 1.25 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Agriculture is the largest reported line at 68.23% of revenue, across 4 reported segments.
- Construction follows at 18.03%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Agriculture68.23%
Construction18.03%
Financial services13.66%
Quote time 2026-10-08 07:06:37 · For reference only, not investment advice and not tailored to your situation.